Southern RNA is an Australian CDMO specializing in the production of nucleic acid products — specifically mRNA vaccines and therapeutics — for their partners. Founded in 2021, Southern RNA offers the manufacture of high-quality mRNA raw material and drug substance. Their ready-to-order products include research-grade mRNA and a proprietary mRNA co-transcriptional cap analog. The company’s CDMO services include cell bank production and flexible, GMP pDNA and mRNA manufacturing. Southern RNA also offers method development and a comprehensive analytical platform for nucleic acid products.